Bio-Rad Laboratories Inc - Class A
Exchange: NYSESector: HealthcareIndustry: Medical Devices
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.
Did you know?
Earnings per share grew at a -13.1% CAGR.
Current Price
$292.23
+1.41%GoodMoat Value
$938.27
221.1% undervaluedProfile
Valuation (TTM)
Market Cap$7.88B
P/E10.37
EV$6.99B
P/B1.06
Shares Out26.97M
P/Sales3.05
Revenue$2.58B
EV/EBITDA7.40
Bio-Rad Laboratories Inc - Class A (BIO) Stock News
BIO Stock News & Headlines
Latest stock news and headlines for Bio-Rad Laboratories Inc - Class A (BIO). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $292.23. Market cap: $7.88B. Sector: Healthcare. Industry: Medical Devices. This page aggregates the latest news articles relevant to BIO from financial news sources, helping investors stay current on events that may impact Bio-Rad Laboratories Inc - Class A's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Bio-Rad Laboratories Inc - Class A (BIO).